(Q36735671)

16 August 2017

1 reference

title

Hormonal management of migraine associated with menses and the menopause: a clinical review (English)

1 reference

16 August 2017

Elizabeth Loder

1

1 reference

16 August 2017

Paul Rizzoli

series ordinal

2

1 reference

16 August 2017

Joan Golub

series ordinal

3

1 reference

16 August 2017

language of work or name

1 reference

1 February 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

47

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

329-340

1 reference

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Prevalence of migraine on each day of the natural menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Characteristics of headache at menopause: a clinico-epidemiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Effects of oestrogen on trigeminal ganglia in culture: implications for hormonal effects on migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Ovarian steroids regulate neuropeptides in the trigeminal ganglion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

17-Beta-estradiol and progesterone modulate an intrinsic opioid analgesic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

The International Classification of Headache Disorders: 2nd edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

"Menstrual" migraine: towards a definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Oestrogen and attacks of migraine with and without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Hormonal factors in migraine: a population-based study of women aged 40 to 74 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Hormone supplementation differently affects migraine in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Migraine and reporoductive hormones throughout the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Migraine prevalence during menopausal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

The normal menopause transition: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Unwanted pregnancies: understanding contraceptive use and benefits in adolescents and older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Defining the relationship between ovarian hormones and migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Migraine Prophylaxis with Lisuride Hydrogen Maleate-A Double Blind Study of Lisuride Versus Placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Headache and Sex Hormone Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Menstruation: choosing whether...and when

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Modern treatments of menorrhagia attributable to dysfunctional uterine bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Phyto-oestrogens in the prophylaxis of menstrual migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Course of primary headaches during hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Efficacy of oral naratriptan in the treatment of menstrually related migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Naratriptan in the short-term prophylaxis of pure menstrual migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

The differential effects of biofeedback in the treatment of menstrual and nonmenstrual migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Role of the needling per se in acupuncture as prophylaxis for menstrually related migraine: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

Recommendations on the Risk of Ischaemic Stroke Associated With Use of Combined Oral Contraceptives and Hormone Replacement Therapy in Women With Migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00710.X

10.1111/J.1526-4610.2006.00710.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference